The current clinical trial paradigm is still subjective relying on in-clinic reported patient outcomes. What if we were able to leverage biosensors to provide passive continuous monitoring to obtain objective real-life data on patients in the home environment? We will discuss how digital and exploratory endpoints can make clinical trials more efficient and how they will redefine clinical research in this new age.